Stecyk Chrystyna Bedrij 4
4 · VACCINEX, INC. · Filed May 12, 2021
Insider Transaction Report
Form 4
VACCINEX, INC.VCNX
Stecyk Chrystyna Bedrij
Director
Transactions
- Award
Stock Option (Right to Buy)
2021-05-11+28,586→ 28,586 totalExercise: $2.15From: 2022-05-11→ Common Stock (28,586 underlying)
Holdings
- 25,087
Stock Option (Right to Buy)
Exercise: $3.95From: 2021-05-14→ Common Stock (25,087 underlying)
Footnotes (2)
- [F1]This option expires on May 12, 2030 or five years following retirement or cessation of services, whichever occurs first.
- [F2]This option was granted pursuant to the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and expires on May 9, 2031 or five years following retirement or cessation of services, whichever occurs first.